Institute of Infection and Immunity (III)
Research
III is dedicated to supporting research and building research capacity in the areas infectious disease and immunity. This broad mandate embraces two priority areas of research, each with multiple themes.
| Research Priorities |
Themes |
| Infectious Disease |
- Antimicrobial Resistance
- Emerging Infectious Diseases
- HIV/AIDS and Hepatitis C
- Microbiologically Safe Food and Water
- Novel Vaccine Development
|
| Host Response |
- Asthma and Allergy
- Autoimmune Diseases
- Innate Immunity
- Organ Transplantation and Regeneration
|
Specific III Research Topics
Within each of these themes, specific III research topics may include, but are not limited to:
- understanding of and treatment for disorders of the immune-system
- design and implementation of health services delivery (e.g. prevention through immunization and case management, diagnosis, intervention or treatment, long-term drug therapy)
- development and implementation of health technologies and tools (e.g. immunization delivery tools)
- development, regulation, and function of the immune system
- viruses, bacteria and other infectious agents and their relationships with humans and other animals
- infectious agents as pathogens - communicable diseases, food and water safety, chronic disease, pathogenesis
- ethics issues related to research, care strategies, and access to care (e.g. clinical trials in developing nations, immigration policy and practice, transplantation, use and misuse of therapeutics)
- health promotion policies and strategies (individual, community, and population based)
- health determinants - to elucidate the multi-dimensional factors that affect the health of populations and lead to a differential prevalence of health concerns
- identification of health advantage and health risk factors related to the interaction of environments (cultural, social, psychological, behavioural, physical, genetic)
- disease and disability prevention strategies at the individual and population levels (e.g. control of global or local disease outbreaks)
- identification of health advantage and health risk factors related to genetic, social and physical environments that influence infection and immunity
- clinical research and health outcomes research (e.g. drug therapies and their applications, diagnostic and treatment technologies, tissue transplantation, treatment and care models).
